3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
60
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Neoplasms
2
Stomach Neoplasms
1
Pancreatic Cancer Resectable
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Locally Advanced Pancreatic Adenocarcinoma
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
Immunohistochemistry
3
Observation
2
Biopsy
2
trastuzumab deruxtecan
1
taxane
1
Watchful Waiting
1
Urination
1
Tomography, X-Ray Computed
1
Tegafur
1
Taxes
1
Surveys and Questionnaires
1
S 1 (combination)
1
Radiofrequency Ablation
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Minimally Invasive Surgical Procedures
1
Microbiota
1
Methylation
1
Mass Spectrometry
1
Liquid Biopsy
1
Leucovorin
1
Irinotecan
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Gemcitabine
1
Frozen Sections
1
Fluorouracil
1
Epirubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Gallbladder Neoplasms
×
Gemcitabine
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled